Here’s the visual proof of why vaccines do more good than harm By Jia You Apr. 27, 2017, 1:15 PM Vaccines have beat back infectious diseases. Bubbles represent reported U.S. ...
A recent Wall Street Journal article addressed the intersection of two major macro trends within the biotech industry: the rise of China-based innovation-driven biotech companies and the continued sourcing of ...
A new consensus has emerged on the CD4+ helper T cell and its role in facilitating and mediating sustained anti-tumor responses. The importance of this cell population has emerged, in ...
June 2-6, McCormick Place, Chicago, IL The ASCO Annual Meeting offers informative educational and scientific sessions that highlight the latest in cancer care treatments. VIEW PRELIMINARY PROGRAM Check out the Preliminary ...
22-24 May 2017, Leiden University Medical Centre, Leiden, The Netherlands Recognition of the skin by vaccinologists as an ideal anatomical target has gathered momentum in the past decade. The premise ...
Meet us in D.C.! May 12-16, 2017 Washington Convention Center Great science awaits you at this, the largest annual gathering of immunologists worldwide. At IMMUNOLOGY 2017™, you’ll hear from global ...
Wednesday, November 8 - Sunday, November 12, 2017 Save the Date! The Society for Immunotherapy of Cancer (SITC) cordially asks you to save the date of our 32nd Annual Meeting ...
BIO Returns to California Location: San Diego Convention Center; 111 W Harbor Dr., San Diego, CA 92101 There’s no better place to connect with biotech’s top people and most innovative ...
Immunomic Therapeutics, a biotechnology company developing a new type of vaccine based on Johns Hopkins research, has reached a $300 million deal licensing its technology to Japanese company Astellas Pharma. ...
THE REMARKABLE SCIENCE BEHIND LAMP TECHNOLOGY – AND ITS POTENTIAL TO TREAT HUMAN DISEASE The body’s own immune system is its best defense against everything from allergies to cancer ...
ROCKVILLE, Md., May 16, 2016 /PRNewswire/ -- At the North Bethesda Marriott, Maryland's leading technology and life science companies gathered to celebrate recent successes from the most innovative teams in the ...
November 08, 2016 07:00 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately-held, Maryland-based biotechnology company, today announced they are now accepting applications for their Cancer Discovery ...